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The Sec6/8 complex is essential for speciﬁc exocytic sites on the plasma membrane and contributes
to membrane growth in mammalian cells. In Madin-Darby canine kidney (MDCK) cells, E-cadherin
and nectin-based adhesion complexes recruit the Sec6/8 complex to intercellular contacts. However,
in cancer cells, the relationship between the Sec6/8 complex and the cell–cell adhesion proteins
remains obscure. We demonstrate that the expression of a-E-catenin is increased by Sec6 siRNAs,
and E-cadherin and b-catenin localize mainly at the cell–cell contact region in HSC3 cells, which
were transfected with Sec6 siRNA.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction cell adhesion is identiﬁed as an essential step of the metastatic pro-Oral cancer is the sixth most common malignancy in humans
and occurs with an increasing frequency worldwide [1]. The
increase in frequency of oral cancer may be related to greater gen-
eral life expectancy, the increasing consumption of alcohol and
tobacco [2], and the involvement of HPV infection [1]. Histologi-
cally, more than 90% of oral cancers are classiﬁed as squamous cell
carcinoma and are derived from the epithelium lining of the oral
cavity. Despite recent advancements in surgery, radiation, and che-
motherapy, treatment of oral squamous cell carcinoma still has a
high failure rate, as many patients present with regional metastasis
at the time of presentation or subsequently develop metastasis
after initial diagnosis [1]. The ﬁve-year survival rate for patients
with lymph node metastasis at presentation notably decreases to
25–40% from a rate of approximately 90% for patients without
lymph node metastasis in oral cancers [3]. Metastasis of cancer
cells involves a series of sequential and interdependent events that
include initial growth, local invasion, angiogenesis, intravasation of
invading cancer cells into the vasculature or lymphatic systems,
extravasation, and subsequent deposition and proliferation at a
second site [1]. In particular, the decrease in cadherin-mediatedchemical Societies. Published by E
y and Cell Biology, School of
-2-2 Iidanishi, Yamagata 990-
(T. Tanaka).cess and tumor progression [1]. Downregulation of E-cadherin-
mediated cell adhesion has been associated with the progression
of various malignant tumors including oral cancers [4]. The adhe-
sive function of cadherins is dependent on their interaction with
catenins [5]. In general, b-catenin links E-cadherin and the actin
cytoskeleton through its interaction with a-E-catenin [5].
The exocyst complex, also called the Sec6/8 complex, is impor-
tant for targeting exocytic vesicles to speciﬁc docking sites on the
plasma membrane in the yeast [6]. In mammalian cells, the Sec6/8
complex has been found in neurons, polarized epithelial cells, exo-
crine cells, and ﬁbroblasts [7–10]. The Sec6/8 complex is essential
for speciﬁc exocytic sites on the plasmamembrane and contributes
to membrane growth in mammalian cells. It is rapidly translocated
from the cytoplasm to the plasma membrane upon initiation of
calcium-dependent cell–cell adhesion [8].
The sec6/8 complex is restricted to plasma membrane sites by
cell–cell adhesion proteins speciﬁc to the apical junctional com-
plex in epithelial cells [11]. In Madin-Darby canine kidney (MDCK)
cells, E-cadherin and nectin-based adhesion complexes recruit the
Sec6/8 complex to intercellular contacts [11]. However, in cancer
cells, the relationship of the Sec6/8 complex and the cell–cell adhe-
sion proteins remains obscure.
In the present study, we demonstrated that Sec6 regulates
E-cadherin and b-catenin through its modulation of the expression
of a-E-catenin. Moreover, Sec8 regulates cell–cell adhesion through
its control of Sec6.lsevier B.V. All rights reserved.
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2.1. Cell lines
Human oral squamous cell carcinoma lines HSC2, HSC3, HSC4,
Ca9-22, and Ho-1-u-1 were obtained from Human Science Re-
search Resources Bank (Osaka, Japan). Cells were maintained in
Dulbecco’s modiﬁed Eagle’s medium (Sigma Chemical Co., St. Louis,
MO) supplemented with 10% heat-inactivated fetal bovine serum
and 100 units/mL penicillin and streptomycin. All cultures were
grown at 37 C in a humidiﬁed atmosphere of 5% carbon dioxide
for routine growth.
2.2. Plasmid construction
The full-length human Sec6 cDNA from HSC-3 cell was cloned
into the HindIII and KpnI sites of the pEGFP-C3 vector (Clontech,
Mountain View, CA). The full-length human a-E-catenin cDNA
from HEK293 cell was cloned into the EcoRI and KpnI sites of the
pEGFP-C2 vector (Clontech). Constructs were conﬁrmed by restric-
tion enzyme analysis and sequencing.
2.3. Ca9-22. cell-stable cell line
Two micrograms of the plasmid GFP vector or GFP-Sec6 were
transfected into Ca9-22 cells using Lipofectamine 2000 (Invitrogen
Co., Carlsbad, CA) according to the manufacturer’s instructions. The
cells were then subcultured at a 1:2 dilution 48 h after the transfec-
tion and selected with G418 (Sigma) at 600 lg/ml to obtain G418-
resistant cell lines. The stably transfected cells were maintained in
the media containing 600 lg/ml of G418. After subcloning by limit-
ing dilution, the single stable clones were expanded. The expression
of GFP or GFP-Sec6 was analyzed by Western blotting.
2.4. Wound healing assay
Wounds were inﬂicted by scratching the surface with a plastic
pipette tip. Images were recorded using the Olympus DP70
(Olympus Corporation, Tokyo, Japan).
2.5. RT-PCR analysis
The total RNA of HeLa cells was extracted using TRIZOL reagent
(Invitrogen). The total RNA of oral cancer cell lines was reverse
transcribed.
Sec6: 50-ACCTAATTGAACAAGGGGCACTCC-30 (sense)
50-CCACGTTCCTCATCATCTCAGTACTTG-30 (antisense)
Sec8: 50-CCT GAT CTC CTG CAT CCT CAT TAA TGG-30 (sense)
50-CGT CAG CTG TGT TGT AAA GCA TCT CGT-30 (antisense)
GAPDH: 50-TTAGCACCCCTGGCCAAGG-30 (sense)
50-CTTACTCCTTGGAGGCCATG-30 (antisense)
GAPDH was used as the control. PCR cycling conditions were 2
min of denaturing at 95C, 30 cycles at 95C, 30 s of denaturing at
60C, 30 s of annealing at 68C, 40 s for extension at 68C, and 1
min for ﬁnal extension. We used a GeneAmp PCR system 9700 (Ap-
plied Biosystems, Foster City, CA). PCR products were inserted into
2% agarose gel, and the band of DNA was photographed with Print-
graph (Atto, Tokyo, Japan) after staining with ethidium bromide.
2.6. Immunoblotting analysis
Transfected cells and cells treated with doxorubicin were lysed
in lysis buffer (20 mM Tris-HCl, pH 7.4, 50 mMNaCl, 1 mMNa3VO4,50 mM NaF, 1% Triton X-100, and protease inhibitor cocktail).
Protein concentration was determined using BCA Protein Assay
Reagent (Pierce, Rockford, IL) according to the manufacturer’s
instructions. The samples were boiled for 5 min in SDS sample buf-
fer (New England Biolabs, Inc., Beverly, MA). Equal amounts of pro-
tein lysate were applied in SDS–PAGE and electrophoretically
transferred onto a PVDF membrane (NENTM Life Science Products,
Inc., Boston, MA). The PVDF membrane was then blocked with 5%
skim milk in PBS-T. The PVDF membranes were immunoblotted
with primary antibodies against Sec6 (1:1000; 9H5; Calbiochem),
Sec8 (1:1000; 14; Santa Cruz), a-tubulin (1:5000; T5168; Sigma),
E-cadherin (1:1000; 4065; Cell Signaling), a-E-catenin (1:1000;
3236; Cell Signaling), b-catenin (1:1000; 9582; Cell Signaling),
and GFP (1:1000; JL-8; Clontech). Immunoreactive complexes were
visualized using the chemiluminescence ECL plus Western blotting
detection system (Amersham Pharmacia Biotech UK Ltd., Bucking-
hamshire, UK).
2.7. RNA interference
Two sets of siRNA duplexes for each targeting protein were used
to knockdown human Sec6 (Sec6-1: HSS117611, Sec6-2:
HSS117612; Stealth Select RNAi, Invitrogen) and human Sec8 (-
Sec8-1: HSS127028, Sec8-2: HSS127029; Stealth Select RNAi, Invit-
rogen) and human a-E-catenin (a-E-catenin-1: SI02654680, a-E-
catenin-2: SI02757377; QIAGEN Inc., Valencia, CA). Stealth RNAi™
siRNA Negative Control was used as the control. HSC3 cells were
transfected with RNAi duplexes using Lipofectamine 2000. At 48
h after transfection, HSC3 cells were used for experiments.
2.8. Immunoﬂuorescence microscopy
Cells were cultured on micro cover glass and rinsed with PBS.
Cells were ﬁxed with 4% paraformaldehyde, washed with PBS three
times, and permeabilized with 0.1% Triton/PBS. Cells were incu-
bated with 10% normal donkey serum for blocking and incubated
with primary antibodies (anti-Sec6 and E-cadherin or b-catenin
or a-E-catenin) overnight at room temperature in a moist chamber.
For immunoﬂuorescent examination, cells were washed with PBS
three times and incubated with anti-rabbit IgG (H+L) Alexa 488
or anti-mouse IgG (H+L) Alexa 647 as the secondary antibody for
1 h. Alexa Fluor 568 phalloidin (Invitrogen) was used for marking
F-actin ﬁlament. The images were observed under a confocal laser
scanning microscope (LSM510META, Carl Zeiss, Jena, Germany).
3. Results
3.1. Sec6 and Sec8 are highly expressed in HSC3 cells
To conﬁrm whether Sec6 and Sec8 are present in human oral
cancer cell lines, we ﬁrst determined whether Sec6 or Sec8 is
expressed in oral cancer cell lines Ca9-22, HSC2, HSC3, HSC4, and
Ho-1-u-1. We performed immunoblotting and RT-PCR analysis.
Although Sec6 and Sec8 proteins were more highly expressed in
HSC3 cells than in other cell lines (Fig. 1A), RT-PCR analysis
revealed that the mRNA expression of Sec6 and Sec8 in HSC3 cells
was not higher than that in other oral cancer cell lines (Fig. 1B).
3.2. Wound healing occurs earlier in HSC3 cells than in other oral
cancer cell lines
HSC3 cells are tongue squamous cell carcinoma-derived meta-
static cell lines, which provide many sublines with high metastatic
potential [12]. To examine cell migration, we performed the
wound healing assay. As shown in Fig. 1C, the width of migrating
Fig. 1. Sec6 is highly expressed in HSC3 cells and wound healing is earlier in HSC3 cells than in other oral cancer cell lines. (A) Whole cell lysates of oral cancer cell lines were
analyzed by immunoblotting with the indicated antibodies. Expression levels of Sec6 and Sec8 were higher in HSC3 cells than in other cell lines. a-tubulin was the loading
control. Band intensities were measured and normalized to a-tubulin. All data are representative of three independent experiments. (B) Expression of Sec6 and Sec8 was
examined by RT-PCR. Expression levels of Sec6 were slightly higher in HSC2, HSC3, and HSC4 cells than in Ca9-22 and Ho-1-u-1 cells. Expression levels of Sec8 were slightly
lower in Ho-1-u-1 cells than in other cell lines. mRNA levels of Sec6 and Sec8 were not higher in HSC3 cells than in other cell lines. GAPDH served as the loading control. (C)
HSC3 cells and Ca9-22 cells were transfected with Scr siRNA. After 48 h, Conﬂuent monolayers of each cell line were wounded by a plastic pipette tip. Wound healing was
recorded 24 h after wounding. Wound healing occurred earlier in HSC3 cells than in Ca9-22 cells.
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than in Ca9-22 cells. Similarly, cell migration was earlier in HSC3
cells than in HSC2, HSC4, and Ho-1-u1 cells (Supplemental Fig. 1).
3.3. Knockdown of Sec6 suppresses wound healing in HSC3 cells
Sec6 was highly expressed in HSC3 cells, and cell migration in
HSC3 cells was earlier than that in other oral cancer cell lines. To
investigate whether Sec6 is related to cell migration, we performed
a wound healing assay in HSC3 cells, in which Sec6 was suppressedwith gene-speciﬁc small interfering RNAs (siRNAs)—Sec6-1 and
Sec6-2 siRNAs. Compared to negative control Scr and Sec6 siRNAs,
repair of the cell monolayer after wounding slowed upon knock-
down of Sec6 siRNA in HSC3 cells (Fig. 2A). This result revealed that
Sec6 requires cell migration in HSC3 cells.
3.4. a-E-catenin increases by knockdown of Sec6 in HSC3 cells
Because Sec6 is involved in cell migration, we then examined
cell–cell adhesion proteins by immunoblotting. Sec6 in HSC3 cells
Fig. 2. Wound healing is slower in HSC3 cells which are transfected with Sec6 siRNAs and a-E-catenin is increased by the knockdown of Sec6 in HSC3 cells. (A) HSC3 cells
were transfected with Scr or Sec6 siRNAs. After 48 h, conﬂuent monolayers of HSC3 cells transfected with Scr or Sec6 siRNAs were wounded with a plastic pipette tip. Wound
healing was recorded 24 h after wounding. The wound healing assay showed that repair of the cell monolayer after wounding slowed with the knockdown of Sec6 siRNAs
compared to the control cells. (B) HSC3 cells were transfected with Scr or Sec6 siRNAs. After 48 h, whole cell lysates were analyzed by immunoblotting with the indicated
antibodies. Although expression levels of Sec8, E-cadherin, and b-catenin did not change, the expression level of a-E-catenin decreased due to knockdown with Sec6 siRNAs.
a-tubulin was the loading control. Band intensities were measured and normalized to a-tubulin and the presented data are mean ± S.D. of three separate experiments.
Asterisks indicate signiﬁcance, ⁄P < 0.01 (Student’s t-test); n.s., not signiﬁcant.
T. Tanaka et al. / FEBS Letters 586 (2012) 924–933 927was suppressed by gene-speciﬁc siRNAs, and immunoblot analysis
revealed that the expression of E-cadherin and b-catenin was not
changed by Sec6 siRNAs (Fig. 2B). Additionally, Sec8, which is a
component of the Sec6/8 complex and concentrates at sites of ves-
icle exocytosis [8], did not change by Sec6 siRNAs (Fig. 2B). On the
other hand, the expression of a-E-catenin was increased by Sec6
siRNAs (Fig. 2B).
Previous research revealed that cultured a-E-catenin–null
keratinocytes increased cell migration [13]. The increase of
a-E-catenin by Sec6 siRNAs is related to slow the repair of the cell
monolayer after wounding (Fig. 2A).These results indicated that Sec6 regulated cell–cell adhesion
by modulating the expression of a-E-catenin.
3.5. Overexpression of Sec6 promotes wound healing in Ca9-22 cells
To investigate the effects of Sec6, we constructed the Sec6-stable
Ca9-22 cell line. As shown in Fig. 3A, cell migration in Sec6-stable
Ca9-22 cells occurred earlier than that in GFP-stable Ca9-22 cells.
This result was similar to the wound healing assay, which was
conducted in HSC3 cells (Fig. 1C), suggesting that overexpression
of Sec6 promotes cell migration.
Fig. 3. Stable expression of Sec6 promotes wound healing in Ca9-22 cells and stable expression of Sec6 suppresses expression of a-E-catenin in Ca9-22 cells. (A) Conﬂuent
monolayers of Ca9-22 cells, which express stable Sec6, were wounded with a plastic pipette tip. Wound healing was recorded 24 h after wounding. The wound healing assay
showed that repair of the cell monolayer after wounding was faster in Ca9-22 cells that express stable Sec6 than in control cells. (B) Whole Ca9-22 cell lysates that expressed
stable Sec6 or GFP were analyzed by immunoblotting with the indicated antibodies. The expression of E-cadherin and b-catenin did not change, but the expression of a-E-
catenin decreased in the Sec6-stable cell line. Band intensities were measured and normalized to a-tubulin and the presented data are mean ± S.D. of three separate
experiments. Asterisks indicate signiﬁcance, ⁄P < 0.01 (Student’s t-test); n.s., not signiﬁcant.
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Ca9-22 cells
We demonstrated that Sec6-stable Ca9-22 cells promoted
greater wound healing than control cells. We performed immuno-
blot analysis to examine whether overexpression of Sec6 inﬂu-
ences E-cadherin, a-E-catenin, and b-catenin. Compared to
control and Sec6-stable Ca9-22 cells, the expression of E-cadherin
and b-catenin did not change, but the expression of a-E-catenin
decreased in the Sec6-stable cell line (Fig. 3B). Inversely, a-E-cate-
nin increases by knockdown of Sec6 in HSC3 cells (Fig. 2B). Theseresults indicate that the expression of Sec6 suppresses the expres-
sion of a-E-catenin.
3.7. Knockdown of Sec6 promotes the localization of E-cadherin,
a-E-catenin, and b-catenin to the cell–cell contact region
The expression of a-E-catenin was increased by Sec6 siRNAs
(Fig. 2B). To investigate the functional implications of the knock-
down of Sec6, we analyzed the subcellular localization of endoge-
nous E-cadherin, b-catenin, and a-E-catenin. We used the
phalloidin to show the relation of F-actin becausea-E-catenin binds
Fig. 4. Knockdown of Sec6 promotes E-cadherin, b-catenin, and a-E-catenin to localize at the cell–cell contact region. (A) In HSC3 cells that were transfected with the
negative control Scr siRNA, endogenous E-cadherin diffusely localized to the cytoplasm and partially localized to the cell–cell contact region and the expression of F-actin
decreased under the plasma membrane. Endogenous E-cadherin mainly localized to the cell–cell contact region and F-actin expressed strongly under the plasma membrane
in HSC3 cells that were transfected with Sec6-2 siRNA. (B) In HSC3 cells that were transfected with the negative control Scr siRNA, endogenous b-catenin diffusely localized to
the cytoplasm and partially localized to the cell–cell contact region and the expression of F-actin decreased under the plasma membrane. Endogenous b-catenin mainly
localized to the cell–cell contact region and F-actin expressed strongly under the plasma membrane in HSC3 cells that were transfected with Sec6-2 siRNA. (C) a-E-catenin
was localized at the cell–cell contact region in HSC3 cells transfected with Sec6-2 siRNA and F-actin expressed strongly under the plasma membrane. a-E-catenin was
distributed predominantly in a perinuclear region and the cytoplasm in HSC3 cells transfected with Scr siRNA. Scale bars = 20 lm.
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plasm [15].
In HSC3 cells, which were the transfected negative control Scr
siRNA, endogenous E-cadherin and b-catenin diffusely localized
in the cytoplasm and partially localized at the cell–cell contact re-
gion and the plasma membrane (Fig. 4A and B, asterisks) and the
expression of F-actin partially decreased under the plasma mem-
brane. Moreover, F-actin expressed strongly under the plasma
membrane and endogenous E-cadherin and b-catenin mainly
localized at the cell–cell contact region in HSC3 cells transfected
with Sec6-2 siRNA (Fig. 4A and B, arrowheads).
Similarly, a-E-catenin was localized at the cell–cell contact
region in HSC3 cells transfected with Sec6-2 siRNA (Fig. 4C, arrow-
heads) and F-actin expressed strongly under the plasmamembrane.
On the other hand, a-E-catenin was distributed predominantly in a
perinuclear region and the cytoplasm in HSC3 cells transfectedwith
Scr siRNA (Fig. 4C).Fig. 5. Knockdown of Sec8 downregulates Sec6 and increases a-E-catenin in HSC3 cells. (
were analyzed by immunoblotting with the indicated antibodies. Although expression lev
catenin decreased by knockdown with Sec8 siRNAs. Band intensities were measured an
experiments. Asterisks indicate signiﬁcance, ⁄P < 0.01 (Student’s t-test); n.s., not signiﬁc
mRNA levels were analyzed by RT-PCR with the indicated primers. mRNA levels of Sec6
control.Similar results were also obtained for HSC3 cells that were
transfected with Sec6-1 siRNA (Supplemental Fig. 2). These results
suggest that Sec6 inhibits the translocation of E-cadherin and b-
catenin to the cell–cell contact region and suppresses the expres-
sion of F-actin.
3.8. Knockdown of Sec8 downregulates Sec6 and increases a-E-catenin
in HSC3 cells
Sec8 is a component of the Sec6/8 (exocyst) complex, which is
recruited to cell–cell contacts in epithelial cells [8]. To investigate
the function of Sec8, we analyzed immunoblotting with the
knockdown of Sec8. Knockdown of Sec8 decreased the Sec6 pro-
tein level (Fig. 5A). We conﬁrmed that knockdown of Sec8 did
not change the Sec6 mRNA level (Fig. 5B). Additionally, knock-
down of Sec8 increased the expression of a-E-catenin and did
not change the expression of E-cadherin and b-catenin. TheseA) HSC3 cells were transfected with Scr or Sec8 siRNAs. After 48 h, whole cell lysates
els of E-cadherin and b-catenin did not change, the expression level of Sec6 and a-E-
d normalized to a-tubulin and the presented data are mean ± SD of three separate
ant. (B) HSC3 cells were transfected with Scr or Sec8 siRNAs. After 48 h, total cell
were not changed by knockdown with Sec8 siRNAs. GAPDH served as the loading
Fig. 6. Overexpression or knockdown of a-E-catenin does not change expression of Sec6 and Sec8 in HSC3 cells. (A) HSC3 cells were transfected with GFP vector or GFP-a-E-
catenin. After 24 h, whole cell lysates were analyzed by immunoblotting with the indicated antibodies. The expression levels of Sec6 and Sec8 did not change. (B) HSC3 cells
were transfected with Scr or a-E-catenin siRNAs. After 48 h, whole cell lysates were analyzed by immunoblotting with the indicated antibodies. The expression levels of Sec6
and Sec8 did not change. Band intensities were measured and normalized to -tubulin and the presented data are mean ± S.D. of three separate experiments. n.s. indicate not
signiﬁcant (Student’s t-test).
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ally, the wound healing assay in HSC3 cells showed that repair of
the cell monolayer after wounding was slower with the knock-
down of Sec8 siRNAs than with the knockdown of Scr siRNAs
(Supplemental Fig. 3). These results indicate that Sec8 regulates
Sec6 and that suppression of Sec6 by Sec8 modulates cell–cell
adhesion.
3.9. Overexpression or knockdown of a-E-catenin does not change
expression of Sec6 and Sec8 in HSC3 cells
To investigate the effects of a-E-catenin, HSC3 cells were trans-
fected with GFP vector or GFP- a-E-catenin. We performed immu-
noblot analysis to examine whether overexpression of a-E-catenin
inﬂuenced Sec6 and Sec8. Compared to control and a-E-catenin-
overexpressed HSC3 cells, the expression of Sec6 and Sec8 did
not change (Fig. 6A). Additionally, we performed immunoblot anal-
ysis to examine whether knockdown of a-E-catenin inﬂuenced
Sec6 and Sec8. Immunoblot analysis revealed that the expression
of Sec6 and Sec8 was not changed by a-E-catenin siRNAs
(Fig. 6B). These results indicate that Sec6 is an upstream regulator
of a-E-catenin.4. Discussion
The Sec6/8 (exocyst) complex is implicated in the targeting of
vesicles for regulated exocytosis in various cell types and impor-
tant for targeted exocytosis of post-Golgi transport vesicles to
the plasma membrane. The complex is formed by Sec3, Sec5,
Sec6, Sec8, Sec10, Sec15, Exo70, and Exo84 [7,8,16–18], and it asso-
ciates with plasma membrane proteins with restricted distribu-
tions to perform this function in the vesicle transport.
In yeast, the Sec6/8 complex is concentrated at sites of active
vesicle exocytosis, such as at the tip of new growing buds [19–21]
and at the neck of the budding cell just before cytokinesis [22]. In
mammalian and yeast cells, the Sec6/8 complex is concentrated
at sites of polarized membrane growth and is related to the mech-
anism of the membrane growth. For example, the Sec6/8 complex
localizes to the axon at sites of synapse formation and at the growth
cone in neurons [23,24].
The Sec6/8 complex localizes to the lateral membrane near the
apical junctional complex in polarized MDCK epithelial cells [8,25].
The Sec6/8 complex localizes to the apical surface, which under-
goes rapid membrane growth upon release of zymogen granules
in exocrine cells [9].
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idly recruited from the cytoplasm to the cell–cell contact region on
initiation of calcium dependent cell–cell adhesion. Moreover, the
localization of the Sec6/8 complex becomes restricted to the apical
junctional complex including adhesion and tight junctions when
cell polarity develops [8].
E-cadherin is an important molecule in cell–cell adhesion; the
interplay between E-cadherin and the Sec6/8 complex is related to
cell–cell contact. In MDCK cells, Sec6 is colocalized with E-cadherin
at early cell–cell contacts [8]. In LE ﬁbroblasts expressing E-cadherin
under the control of the dexamethasonepromoter, Sec6/8was local-
ized to cell–cell contacts only when both E-cadherin and nectin-2 a
were expressed at and colocalized to the contact [11]. Our results
revealed that the suppression of Sec6 or Sec8 by siRNA did not
inﬂuence the expression of E-cadherin and b-catenin, but instead
increased the expression of a-E-catenin in HSC3 cells. Moreover,
the suppression of Sec6 inhibited wound healing and promoted
E-cadherin, b-catenin, and a-E-catenin to localize to cell–cell con-
tacts. Although our data (Fig 4) seem to conﬂict with previous
reports [8,11], the mechanism by which the Sec6/8 complex acts
in cell–cell adhesion may be impaired in cancer cells.
a-E-catenin was initially identiﬁed on the basis of its ability to
associate with E-cadherin [26,27]. Gene-targeting studies in mice
indicate that a-E-catenin is required to mediate the formation of
adherens junctions in epithelial cells [13,28]. When newly synthe-
sized E-cadherin associates with b-catenin in the endoplasmic
reticulum, a-E-catenin seems to join the E-cadherin–b-catenin
complex only after it has reached the plasma membrane [29]. Con-
versely, detachment of a-E-catenin and actin from the E-cadherin–
b-catenin complex has been observed during the disassembly of
adherens junctions [30].
Moreover, cancer cell lines that lack a-E-catenin have incom-
plete cell–cell adhesion [31]. The proportion of malignant tumors
that lack either E-cadherin and a-E-catenin or both has been
reported to be as high as 80%, and the loss of E-cadherin or
a-E-catenin is often correlated with the degree of tumor differen-
tiation and metastasis [32,33]. The loss of a-E-catenin seems to
be the more common event and also correlates better than the loss
of E-cadherin with the level of invasiveness of a tumor and with its
degree of differentiation [32,33].
Our results indicate that Sec8 regulates the expression of Sec6
and that Sec6 regulates the expression of a-E-catenin in cancer
cells. Therefore, it is possible that the expression of Sec6 or Sec8
is associated with the degree of differentiation and metastasis in
cancer cells. Furthermore, it is not well known what protein mod-
iﬁcations are involved in the selective recruitment of a-E-catenin
to the E-cadherin–b-catenin complex at the plasma membrane
[34]. In this regard, the Sec6/8 complex is a candidate for recruiting
a-E-catenin to the E-cadherin–b-catenin complex at the plasma
membrane.
However, it is unclear how Sec6 and Sec8 downregulate the
expression of a-E-catenin. To address this question, Rho-family
GTPases may be key molecules for study. Rho-family GTPases,
including Rho, Rac, and Cdc42, participate in regulating cadherin-
mediated cell adhesion [35]. Some researchers have reported that
the components of the exocyst complex are closely related to
Rho-family GTPases.
In yeast, Sec3, which is a component of the Sec6/8 complex, is a
downstream effector of both Cdc42 and Rho1. GTP-binding Rho1
and Cdc42 compete to bind to the N-terminal region of Sec3, lead-
ing to the speculation that they control Sec3 localization at differ-
ent cell cycle stages or growth conditions [36]. Moreover, Exo70,
which is a component of the Sec6/8 complex, is shown to interact
with the GTP-bound form of Rho3, which is implicated in exocyto-
sis [37]. Exo70 interacts with TC10, which is a homolog of Cdc42,and this interaction is shown to be important for the fusion, rather
than the delivery, of Glut4 vesicles to the plasma membrane in adi-
pocytes in response to insulin [38]. Further research is needed to
investigate whether the Sec6/8 complex is related to the degree
of malignancy and how the Sec6/8 complex modulates the expres-
sion of a-E-catenin in cancer cells.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.febslet.2012.02.026.
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